APP and Alzheimer disease: Although overproduction or accumulation of Aβ, which is generated from its precursor protein (APP), is considered to have a leading role in AD pathophysiology [2], most clinical trials targeting this mechanism have failed, indicating that the mechanisms in the early stages of AD need further exploration.